Postoperative Exercise Training and Colorectal Cancer Liver Metastasis
POET-mCRC
Post-Operative Exercise Training in Patients With Metastatic Colorectal Cancer
1 other identifier
interventional
66
1 country
1
Brief Summary
Up to 25% of colorectal cancer (CRC) patients are diagnosed with liver metastases, which is the most common site of metastasis, already during the primary tumor diagnosis. Another 30% of the patients will develop liver metastases at a later stage. Even though patient can be treated by surgical resection of the metastatic tumor, 50-75% of the patients experience a relapse in less than two years. Due to the high probability of relapse, mCRC patients undergo multiple rounds of surgery and adjuvant treatment (chemotherapy/radiotherapy) which results in substantial physical de-conditioning. Physical activity has been shown to increase the progression-free survival rates in mCRC patients, when applied post-diagnosis. Increased cardiorespiratory fitness (VO2peak) at the time of diagnosis among CRC individuals has been associated with lower risk of all-cause mortality. Although data on the effect of chronic exercise on VO2peak have emerged, thus far, there is no randomized clinical trial that has investigated the effects of exercise training in mCRC patients early after surgical treatment with curative intent. Therefore, this project aims to address the beneficial effect of structured exercise training primarily on VO2peak and tumor recurrence in mCRC patients immediately after surgical treatment and while they are undergoing adjuvant chemotherapy/radiotherapy. A total of 66 participants will be recruited from the Department of Surgery and Transplantation, Rigshospitalet and randomly allocated to a standard care control group (n=22), standard care plus 150 min/week exercise training (n=22) or standard care plus 300 min/week exercise training (n=22). Participants will undergo exercise training for 6 months, starting immediately after surgery, and they will be followed for additional 6 months. Tumor recurrence will be evaluated up to 3 years after training initiation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2022
CompletedFirst Posted
Study publicly available on registry
October 13, 2022
CompletedStudy Start
First participant enrolled
April 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
February 24, 2026
February 1, 2026
3.1 years
September 22, 2022
February 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in peak oxygen consumption (VO2peak)
Changes in VO2peak assessed during an incremental exercise test to volitional exhaustion on a bicycle ergometer
Baseline, 3-, 6-, 9- and 12 months after exercise training initiation
Secondary Outcomes (62)
3-years recurrence-free survival
Randomization to 3 years after randomization
3-years overall survival
Randomization to 3 years after randomization
Changes in Aerobic Capacity: Ventilatory threshold
Baseline, 3-, 6-, 9- and 12 months after exercise training initiation
Changes in Aerobic Capacity: Peak power output
Baseline, 3-, 6-, 9- and 12 months after exercise training initiation
Changes in Muscle strength: Hand grip strength
Baseline, 3-, 6-, 9- and 12 months after exercise training initiation
- +57 more secondary outcomes
Study Arms (3)
Usual care
NO INTERVENTIONEx1
EXPERIMENTALLow exercise volume (150 min/week)
Ex2
EXPERIMENTALHigh exercise volume (300 min/week)
Interventions
Eligibility Criteria
You may qualify if:
- Colorectal cancer patients diagnosed with liver metastasis and scheduled for liver metastasis surgical resection
You may not qualify if:
- Age \<18
- Pregnancy
- Physical or mental disabilities that prohibit execution of test or training procedures
- Inability to understand the Danish language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet (CFAS)
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Casper Simonsen, PhD
Group Leader
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral researcher
Study Record Dates
First Submitted
September 22, 2022
First Posted
October 13, 2022
Study Start
April 18, 2023
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2028
Last Updated
February 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share